Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The EBMT Handbook [[electronic resource] ] : Hematopoietic Stem Cell Transplantation and Cellular Therapies / / edited by Enric Carreras, Carlo Dufour, Mohamad Mohty, Nicolaus Kröger
| The EBMT Handbook [[electronic resource] ] : Hematopoietic Stem Cell Transplantation and Cellular Therapies / / edited by Enric Carreras, Carlo Dufour, Mohamad Mohty, Nicolaus Kröger |
| Autore | Carreras Enric |
| Edizione | [7th ed. 2019.] |
| Pubbl/distr/stampa | Cham, : Springer Nature, 2019 |
| Descrizione fisica | 1 online resource (XL, 702 p. 56 illus., 38 illus. in color.) |
| Disciplina | 616.15 |
| Soggetto topico |
Hematology
Surgical transplantation Blood transfusion Pediatric surgery Surgical oncology Hematopoietic Stem Cell Transplantation Leukemia - therapy |
| Soggetto non controllato |
Medicine
Hematology Surgical transplantation Blood transfusion Pediatric surgery Surgical oncology |
| ISBN | 3-030-02278-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1. Introduction -- 1. HSCT: Historical perspective -- 2. The EBMT: History, present and future -- 3. The role of unrelated donor registries in HSCT -- 4. The HSCT Unit -- 5. JACIE accreditation of HSCT programs -- 6. Statistical methods in HSCT and Cellular Therapies -- Part 2. Biological aspects -- 7. Biological properties of HSC: scientific basis for HSCT -- 8. Biological properties of cells other than HSC -- 9. Histocompatibility -- 10. Clinical & biological concepts for mastering Immune reconstitution after HSCT: towards practical guidelines and greater harmonization -- Part 3. Methodology and clinical aspects -- 11. Evaluation and counselling of candidates -- 12. Donor selection for adults and pediatrics -- 13. Conditioning -- 14. Bone marrow harvesting for HSCT -- 15. Mobilization and collection of HSC -- 16. Collection of HSC in children -- 17. Processing, cryopreserving, and controlling the quality of HSCs -- 18. Procurement and management of cord blood -- 19. Graft manipulation -- 20. Documentation of engraftment and chimerism after HSCT -- 21. Short and long-term controls after HSCT -- Part 4. General management of the patient -- 22. Vascular access -- 23. Transfusion support -- 24. Nutritional support -- 25. GVHD prophylaxis (immunosuppression) -- 26. Management ATG (SIRS) -- 27. Infections control and isolation procedures -- 28. General management of the patient; Specific aspects of children -- 29. Vaccinations -- 30. Psychological morbidity and support -- 31. Clinical relevant drug interactions in HSCT -- 32. Role of nursing in HSCT -- 33. Ethical issues in HSCT -- 34. Quality of life assessment after HSCT for pediatric and adults -- Part 5. HSCT complications and management -- 35. Neutropenic fever -- 36. Bacterial infections -- 37. Invasive fungal infections -- 38. Viral infections -- 39. Other life-threatening infections -- 40. Bleeding and thrombotic complications -- 41. Graft failure -- 42. Early complications of endothelial origin -- 43. Acute Graft-versus-Host Disease -- 44. Chronic Graft-versus-Host Disease -- 45. Post-transplant lymphoproliferative syndromes -- 46. Iron overload -- 47. Secondary neoplasia (other than PTLPS) -- Part 6. Specific organ complications -- 48. Ocular and oral complications -- 49. Hepatic complications -- 50. Gastrointestinal complications -- 51. Hemorrhagic cystitis and renal dysfunction -- 52. Non-infectious pulmonary complications -- 53. Neurological complications -- 54. Skin, hair and musculoskeletal complications -- 55. Cardiovascular diseases and metabolic syndrome -- 56. Endocrine disorders, fertility and sexual health -- Part 7. Prevention and management of relapse -- 57. Monitoring MRD in ALL and AML -- 58. Preventing/treating relapse with drugs -- 59. Delayed transfer of immune cells, or the art of Donor Lymphocyte Infusion -- 60. Cellular therapy with engineered T cells, efficacy and side effects -- 61. Mechanisms of Immune resistance -- 62. Regulatory Aspects of ATMP versus minimally manipulated immune cells -- Part 8. Specific modalities of HSCT and management -- 63. At-home HSCT -- 64. Umbilical cord blood transplantation in children and adults -- 65. Haploidentical HSCT -- 66. Photopheresis in adults and pediatrics -- 67. Overweight and obese patients -- 68. HSCT in elderly patients -- Part 9. Indications and results -- 69. Acute Myeloid Leukemia in adults -- 70. Acute Myeloid Leukemia in children -- 71. Acute Lymphoblastic Leukemia in adults -- 72. Acute lymphoblastic leukemia in children and adolescents -- 73. Myelodysplastic syndromes -- 74. Pediatric MDS including Refractory Cytopenia and Juvenile Myelomonocytic Leukemia -- 75. Myelodysplastic/myeloproliferative neoplasms -- 76. Myeloproliferative neoplasms -- 77. Severe aplastic anemia and PNH -- 78. Fanconi anemia and other hereditary Bone Marrow Failure syndromes -- 79. Hemoglobinopathies (Sickle Cell Disease and Thalassemia) -- 80. Multiple myeloma -- 81. Systemic light chain amyloidosis -- 82. POEMS syndrome and disease produced by other monoclonal immunoglobulins -- 83. Follicular lymphoma -- 84. Chronic lymphocytic leukemia -- 85. Diffuse large B cell lymphoma -- 86. Mantle cell lymphoma -- 87. Other T- and B-aggressive lymphomas and lymphomas associated to HIV -- 88. Classical Hodgkin’s lymphoma -- 89. Primary immunodeficiencies -- 90. Inborn error of metabolism and osteopetrosis -- 91. Autoimmune disease -- 92. Solid tumors. |
| Record Nr. | UNINA-9910337530503321 |
Carreras Enric
|
||
| Cham, : Springer Nature, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The EBMT Handbook [[electronic resource] ] : Hematopoietic Cell Transplantation and Cellular Therapies / / edited by Anna Sureda, Selim Corbacioglu, Raffaella Greco, Nicolaus Kröger, Enric Carreras
| The EBMT Handbook [[electronic resource] ] : Hematopoietic Cell Transplantation and Cellular Therapies / / edited by Anna Sureda, Selim Corbacioglu, Raffaella Greco, Nicolaus Kröger, Enric Carreras |
| Edizione | [8th ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (XLII, 862 p. 62 illus., 47 illus. in color.) |
| Disciplina | 616.15 |
| Soggetto topico |
Hematology
Transplantation of organs, tissues, etc Internal medicine Children - Surgery Cancer - Treatment Transplantation Internal Medicine Pediatric Surgery Cancer Therapy |
| ISBN | 3-031-44080-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I . Introduction -- 1. HCT: Historical Perspective -- 2. The EBMT: History, Present, and Future -- 3. Registries – a bridge between donor and recipient -- 4. The HCT Unit -- 5. JACIE Accreditation of HCT Programs -- 6. Statistical Methods in HCT and Cellular Therapies -- Part II . Biological Aspects -- 7. Biological Properties Of Hematopoietic Stem Cells: Scientific Basis For Hematopoietic Cell Transplantation -- 8. Biological Properties of Cells Other Than HSCs -- 9. Histocompatibility -- 10. Clinical and biological concepts for mastering immune reconstitution after hematopoietic cell transplantation: towards practical guidelines and greater harmonization -- Part III . Methodology and Clinical Aspects -- 11. Evaluation and Counseling of Candidates -- 12. Donor Selection for Adults and Pediatrics -- 13. Conditioning -- 14. Selection of stem cell source -- 15. Bone Marrow Harvesting for HCT -- 16. Mobilization and Collection of HSC -- 17. Mobilization and Collection of HSC in Children -- 18. Procurement and Management of Cord Blood Unit for allogeneic transplantation -- 19. Graft Manipulation -- 20. Processing, Cryopreserving and Controlling the Quality of HSC -- 21. Documentation of Engraftment and Chimerism After HCT -- 22. Short- and Long-Term Controls After HCT -- Part IV . General Management of the Patient -- 23. Vascular Access -- 24. Transfusion Support -- 25. Nutritional Support -- 26. GVHD Prophylaxis -- 27. Infection Control and Isolation Procedures -- 28. General Management of the Patient: Specific Aspects of Infectious Disease Supportive Care in Children -- 29. Vaccinations -- 30. Psychological Morbidity and Care -- 31. Clinically Relevant Drug Interactions in HCT -- 32. The Roles of the HCT Nurse -- 33. Ethical Issues in HCT -- 34. Quality of Life Assessment After HCT for Pediatric and Adults -- Part V. HCT Complications and Management -- 35. Neutropenic Fever -- 36. Bacterial Infections -- 37. Invasive fungal diseases -- 38. Viral Infections -- 39. Other Life-Threatening Infections -- 40. Bleeding and Thrombotic Complications -- 41. Graft Failure -- 42. Early complications of endothelial origin -- 43. Acute Graft-Versus-Host Disease -- 44. Chronic Graft-Versus-Host Disease -- 45. Post-transplant lymphoproliferative syndromes -- 46. Iron Overload -- 47. Secondary Neoplasia (Other than PTLPS) -- Part VI . Specific Organ Complications -- 48. Ocular and Oral Complications -- 49. Hepatic complications -- 50. Gastrointestinal Complications -- 51. Haemorrhagic Cystitis and Renal Dysfunction -- 52. Noninfectious Pulmonary Complications -- 53. Neurological Complications -- 54. Skin, Hair and Musculoskeletal Complications -- 55. Cardiovascular Diseases and Metabolic Syndrome -- 56. Endocrine Disorders, Fertility and Sexual Health -- Part VII . Prevention and Management of Relapse -- 57. Monitoring Measurable Residual Disease in ALL and AML -- 58. Prevention and Treatment of Relapse by Drugs -- 59. Delayed transfer of immune cells, or the art of donor lymphocyte infusion (DLI) 2.0 -- 60. Cellular Therapy with Engineered T Cells, Efficacy and Side Effects: Gene Editing/Gene Therapy -- 61. Mechanisms of Immune Resistance -- 62. Regulatory Aspects Of Atmp Versus Minimally Manipulated Immune Cells -- Part VIII . Specific Modalities of HCT and Management -- 63. At Home HCT -- 64. Role Of Umbilical Cord Blood Transplantation -- 65. Haploidentical HCT -- 66. Photopheresis in Adults and Pediatrics -- 67. Overweight and obese patients -- 68. HCT in Elderly Patients -- 69. Feasibility and Experiences of HCT in Resource-constrained Settings -- Part IX . Indications and Results -- 70. AML in adults -- 71. Acute Myeloid Leukemia in Children -- 72. Acute Lymphoblastic Leukemia in Adults -- 73. Acute Lymphoblastic Leukemia in Children and Adolescents -- 74. Myelodysplastic Neoplasms/Syndromes (MDS) -- 75. Allogeneic hematopoietic cell transplantation in pediatric MDS including refractory cytopenia of childhood and in juvenile myelomonocytic leukemia -- 76. Myelodysplastic/Myeloproliferative Neoplasms -- 77. Myeloproliferative Neoplasms -- 78. Acquired bone marrow failure: Severe Aplastic Anemia and Paroxysmal nocturnal hemoglobinuria -- 79. Fanconi Anemia and Other Hereditary Bone Marrow Failure Syndromes -- 80. Hemoglobinopathies (Sickle Cell Disease and Thalassemia) -- 81. Multiple Myeloma -- 82. Systemic Light Chain Amyloidosis -- 83. Poems Syndrome And Disease Produced By Other Monoclonal IGS -- 84. Indolent Lymphoma -- 85. CHRONIC LYMPHOCYTIC LEUKEMIA -- 86. Large B-Cell Lymphoma -- 87. Mantle Cell Lymphoma -- 88. Other B- and T-Aggressive Lymphomas & Lymphomas Associated with HIV -- 89. Classical Hodgkin’s Lymphoma -- 90. Inborn errors of immunity -- 91. Inborn Errors of Metabolism and Osteopetrosis -- 92. Autoimmune Disease -- 93. CART cells & other cell therapies (ie MSC, Tregs) in autoimmune diseases -- 94. Solid Tumours. |
| Record Nr. | UNINA-9910847596303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||